Yes, carrier testing is a type of genetic testing that can identify whether you carry a mutation for certain genetic conditions, even if you do not have any symptoms of the condition yourself. This information can be useful for family planning and understanding your risk of passing on genetic conditions to your children.
Yes, genetic testing can be performed on children to determine their risk of inheriting a genetic condition from one or both parents. This information can be valuable for parents who may be carriers of a genetic mutation and want to understand their child’s risk and potential healthcare needs.
The interpretation of genetic testing results can be complex, so it’s important to discuss them with a healthcare provider or geneticist who can help you understand what they mean for your health and future medical care. They will provide guidance on any preventive measures or screening recommendations based on your results.
No, mRNA testing is not the same as DNA testing. DNA testing analyses an individual’s genetic material (DNA) to identify genetic variations, mutations, or predispositions to certain diseases. It provides information about an individual’s inherited genetic makeup. On the other hand, mRNA testing analyses messenger RNA (mRNA) molecules, which are used to produce proteins. mRNA testing is often used to measure gene expression levels, providing insights into which genes are active or inactive in a particular tissue or sample. While both types of testing are molecular techniques used in genetics and medical diagnostics, they serve different purposes.
The turnaround time would be 6 to 10 weeks.
Yes, mRNA testing can be used to monitor changes in gene expression patterns in response to cancer treatments, such as chemotherapy or targeted therapy. This information can help oncologists assess the effectiveness of treatment and make adjustments as needed to improve patient outcomes. While mRNA testing isn’t typically used as a direct method for monitoring treatment response in cancer patients, it can play a role in profiling the tumour microenvironment to predict response to immunotherapy at the time of diagnosis or during disease progression. Changes in gene expression profiles may occur over time. Monitoring these changes using mRNA testing isn’t a standard approach for assessing treatment response. Instead, treatment response is typically evaluated through various methods such as imaging scans, blood tests, and clinical assessments. mRNA testing’s primary role remains in predicting response to immunotherapy rather than directly monitoring treatment response.
Yes, we do provide COVID-19 PCR test.
Yes, but the prices for pre-booked and walk-in are different.
Go to, www.mygenome.asia and click on Our Services→ Medical Laboratory→ Molecular Tests→ COVID-19 RT-PCR to make your booking.
You should come at 8.30 am to 10.30 am (daily) for a swab test.
The COVID-19 PCR report will be release by 7 PM on the same day.
The COVID-19 PCR sample will be processed the following day and the report will be released before 7 PM.
Yes, we do provide microbial test for the purpose of product quality control.
Mycoplasma:
A mycoplasma test is used to detect the presence of mycoplasma (a group of bacteria that lack cell walls and can cause significant interference in research and bioproduction) contamination in biological samples such as cell cultures, tissue cultures and clinical specimens.
Bacterial Endotoxin Test:
Bacterial Endotoxins Test (BET), also known as the Limulus Amebocyte Lysate (LAL) test, is a widely used assay to detect and quantify endotoxins from Gram negative bacteria in pharmaceuticals, medical devices, and other products. Endotoxins are lipopolysaccharide (LPS) components of the outer membrane of Gram-negative bacteria, which can cause severe immune response in humans.
Sterility Testing:
Sterility testing is a critical quality control measure used to ensure the safety, efficacy, and quality of pharmaceuticals, medical devices, biologics, and other healthcare products.
By verifying the absence of viable microorganisms, sterility testing helps protect patients from the risk of infection or other adverse reactions associated with product contamination.
Yes. MyGenome ensure that our microbial test methods comply with regulatory and international standards of compliance. This includes Mycoplasma Detection (EP 2.6.7), Bacterial Endotoxin (USP <85>) and Sterility (USP <71>/EP (2.6.1)/JP (4.06)).
Mycoplasma & Bacterial Endotoxin Tests: within 2 days following sample receive date.
Sterility Testing: within 16 days following sample receive date.
Please contact out marketing team, Globemedic, at 03-2181 5665, for further details on pricing and available packages at our lab.
Please call 019-266 6213 to speak to a Mandarin speaking staff.
We are located at Suite No. 03-04, Ground Floor, Menara See Hoy Chan, No. 374, Jalan Tun Razak, Kuala Lumpur.
You can reach us through:
Call: 03-2161 6113
Email: info@mygenome.asia
Or through ALPS Global Holding Berhad
Call: 03-2163 1113
